Systematic review of adjuvant sulfasalazine in the treatment of ulcerative colitis
DOI: 10.23977/medsc.2022.030217 | Downloads: 31 | Views: 1062
Author(s)
Hui Zhang 1, Yi Li 2, Yujiao Xue 1, Changan Zhou 1
Affiliation(s)
1 Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China
2 The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China
Corresponding Author
Yi LiABSTRACT
The incidence of ulcerative colitis is concentrated in those with a high educational level such as universities. The incidence is mainly young and middle-aged, and the occupational pressure is high, such as teachers and technicians, and the incidence of ulcerative colitis is not obvious in men and women. Difference; the disease can occur at any age, but more common in young adults. Its main symptoms are stool mucus pus and blood, abdominal pain, increased stool frequency, fatigue, loose stools, poor sleep, dry mouth, cold body and cold limbs, impatience, tenesmus, etc. OBJECTIVE: This study compared mesalazine and sulfasalazine to study the systematic review of sulfasalazine in the adjuvant treatment of ulcerative colitis. Methods: A total of 62 patients admitted to the hospital were selected and divided into two groups by random number method. They were treated respectively. The treatment effect, the frequency of defecation, diarrhea, abdominal pain and the incidence of adverse reactions were compared between the two groups before and after treatment. Results: The two groups of patients were compared after treatment, and the difference was statistically significant. The results showed that by comparing and analyzing the gender, age and other basic data of the two groups of patients, the curative effect of sulfasalazine was better, and the difference was not statistically significant (P>0.05), which was comparable.
KEYWORDS
Sulfasalazine, adjunctive therapy, ulcerative colitisCITE THIS PAPER
Hui Zhang, Yi Li, Yujiao Xue, Changan Zhou, Systematic review of adjuvant sulfasalazine in the treatment of ulcerative colitis. MEDS Clinical Medicine (2022) Vol. 3: 100-104. DOI: http://dx.doi.org/10.23977/medsc.2022.030217.
REFERENCES
[1] Eichele D D, Kharbanda K K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis [J]. World Journal of Gastroenterology, 2017(33): 6016-6029.
[2] Fujikawa H, Araki T, Okita Y, et al. Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis [J]. Surgery Today, 2017, 47(1): 1-7.
[3] Dan T, Baruch Y, Michal K, et al. Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial [J]. Journal of Crohns & Colitis, 2017, 11(5): 527.
[4] AE Khodir, Atef H, Said E, et al. Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis [J]. Inflammopharmacology, 2017, 25(1): 1-17.
[5] Zong S, Ye H, Ye Z, et al. Polysaccharides from Lachnum sp. Inhibited colitis-associated colon tumorigenesis in mice by modulating fecal microbiota and metabolites [J]. International Immunopharmacology, 2022, 108(3): 108656.
[6] FaNg W, Ke W, Wei X, et al. SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice [J]. Cell Reports, 2017, 19(11): 2331-2344.
[7] Fugmann T, Sofron A, Ritz D, et al. The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis [J]. Journal of Immunology, 2017, 198(3): 1357.
[8] ChiriAc M T, Buchen B, Wandersee A, et al. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing inMice with Colitis and Is Increased in Mucosa of Patients WithInflammatory Bowel Disease [J]. Gastroenterology, 2017, 153(1): 123-138.
[9] Xiao yong, Chen, Xin, et al. Prevent Effects of Lactobacillus Fermentum HY01 on Dextran Sulfate Sodium-Induced Colitis in Mice[J]. Nutrients, 2017, 9(6):545.
[10] Nanjundappa R H, Ronchi F, Wang J, et al. A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress Colitis. [J]. Cell, 2017, 171(3): 655.
[11] B S Y Z A, A Y Q P, A B L X, et al. Study on the physicochemical properties and anti-inflammatory effects of paeonol in rats with TNBS-induced ulcerative colitis [J]. International Immunopharmacology, 2017, 42: 32-38.
[12] Wang D Y, Fei Y, Zhao S, et al. Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis. [J]. Oncoimmunology, 2017, 6(12): e1344805.
Downloads: | 4166 |
---|---|
Visits: | 181223 |
Sponsors, Associates, and Links
-
Journal of Neurobiology and Genetics
-
Medical Imaging and Nuclear Medicine
-
Bacterial Genetics and Ecology
-
Transactions on Cancer
-
Journal of Biophysics and Ecology
-
Journal of Animal Science and Veterinary
-
Academic Journal of Biochemistry and Molecular Biology
-
Transactions on Cell and Developmental Biology
-
Rehabilitation Engineering & Assistive Technology
-
Orthopaedics and Sports Medicine
-
Hematology and Stem Cell
-
Journal of Intelligent Informatics and Biomedical Engineering
-
MEDS Basic Medicine
-
MEDS Stomatology
-
MEDS Public Health and Preventive Medicine
-
MEDS Chinese Medicine
-
Journal of Enzyme Engineering
-
Advances in Industrial Pharmacy and Pharmaceutical Sciences
-
Bacteriology and Microbiology
-
Advances in Physiology and Pathophysiology
-
Journal of Vision and Ophthalmology
-
Frontiers of Obstetrics and Gynecology
-
Digestive Disease and Diabetes
-
Advances in Immunology and Vaccines
-
Nanomedicine and Drug Delivery
-
Cardiology and Vascular System
-
Pediatrics and Child Health
-
Journal of Reproductive Medicine and Contraception
-
Journal of Respiratory and Lung Disease
-
Journal of Bioinformatics and Biomedicine